Literature DB >> 28213521

Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.

Melanie K B Wills1, Ava Keyvani Chahi1, Hayley R Lau1, Manali Tilak1, Brianna D Guild1, Laura A New1, Peihua Lu1, Kévin Jacquet2, Susan O Meakin3, Nicolas Bisson2, Nina Jones4.   

Abstract

Proteins of the Src homology and collagen (Shc) family are typically involved in signal transduction events involving Ras/MAPK and PI3K/Akt pathways. In the nervous system, they function proximal to the neurotrophic factors that regulate cell survival, differentiation, and neuron-specific characteristics. The least characterized homolog, ShcD, is robustly expressed in the developing and mature nervous system, but its contributions to neural cell circuitry are largely uncharted. We now report that ShcD binds to active Ret, TrkA, and TrkB neurotrophic factor receptors predominantly via its phosphotyrosine-binding (PTB) domain. However, in contrast to the conventional Shc adaptors, ShcD suppresses distal phosphorylation of the Erk MAPK. Accordingly, genetic knock-out of mouse ShcD enhances Erk phosphorylation in the brain. In cultured cells, this capacity is tightly aligned to phosphorylation of ShcD CH1 region tyrosine motifs, which serve as docking platforms for signal transducers, such as Grb2. Erk suppression is relieved through independent mutagenesis of the PTB domain and the CH1 tyrosine residues, and successive substitution of these tyrosines breaks the interaction between ShcD and Grb2, thereby promoting TrkB-Grb2 association. Erk phosphorylation can also be restored in the presence of wild type ShcD through Grb2 overexpression. Conversely, mutation of the ShcD SH2 domain results in enhanced repression of Erk. Although the SH2 domain is a less common binding interface in Shc proteins, we demonstrate that it associates with the Ptpn11 (Shp2) phosphatase, which in turn regulates ShcD tyrosine phosphorylation. We therefore propose a model whereby ShcD competes with neurotrophic receptors for Grb2 binding and opposes activation of the MAPK cascade.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RaLP; ShcD; Shp2; TRK1-transforming tyrosine kinase protein (Trk-A); TrkB; extracellular signal-regulated kinase (ERK); growth factor receptor-bound protein 2 (GRB2); neurotrophin; phosphotyrosine adaptor; signal transduction

Mesh:

Substances:

Year:  2017        PMID: 28213521      PMCID: PMC5392570          DOI: 10.1074/jbc.M116.770511

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

Authors:  E Migliaccio; S Mele; A E Salcini; G Pelicci; K M Lai; G Superti-Furga; T Pawson; P P Di Fiore; L Lanfrancone; P G Pelicci
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

2.  The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.

Authors:  S Okada; A W Kao; B P Ceresa; P Blaikie; B Margolis; J E Pessin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

3.  Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB.

Authors:  Emi Kumamaru; Tadahiro Numakawa; Naoki Adachi; Hiroshi Kunugi
Journal:  FEBS Lett       Date:  2011-09-19       Impact factor: 4.124

4.  ShcD interacts with TrkB via its PTB and SH2 domains and regulates BDNF-induced MAPK activation.

Authors:  Yuangang You; Weiqi Li; Yanhua Gong; Bin Yin; Boqin Qiang; Jiangang Yuan; Xiaozhong Peng
Journal:  BMB Rep       Date:  2010-07       Impact factor: 4.778

5.  The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Giuliana Pelicci; Flavia Troglio; Alessandra Bodini; Rosa Marina Melillo; Valentina Pettirossi; Laura Coda; Antonio De Giuseppe; Massimo Santoro; Pier Giuseppe Pelicci
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 6.  Novel functions and signalling pathways for GDNF.

Authors:  Hannu Sariola; Mart Saarma
Journal:  J Cell Sci       Date:  2003-10-01       Impact factor: 5.285

Review 7.  Trk receptor expression and inhibition in neuroblastomas.

Authors:  Garrett M Brodeur; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Carly R Varela; Jennifer E Light; Venkatadri Kolla; Audrey E Evans
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

8.  Podocyte Protein, Nephrin, Is a Substrate of Protein Tyrosine Phosphatase 1B.

Authors:  Lamine Aoudjit; Ruihua Jiang; Tae Hoon Lee; Laura A New; Nina Jones; Tomoko Takano
Journal:  J Signal Transduct       Date:  2011-10-15

9.  The Shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation.

Authors:  Micol Ferro; Maria Teresa Savino; Barbara Ortensi; Francesca Finetti; Luca Genovese; Giulia Masi; Cristina Ulivieri; Daniela Benati; Giuliana Pelicci; Cosima T Baldari
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

10.  SAINTexpress: improvements and additional features in Significance Analysis of INTeractome software.

Authors:  Guoci Teo; Guomin Liu; Jianping Zhang; Alexey I Nesvizhskii; Anne-Claude Gingras; Hyungwon Choi
Journal:  J Proteomics       Date:  2013-10-26       Impact factor: 4.044

View more
  5 in total

Review 1.  Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging.

Authors:  Itzel Ortiz Flores; Samuel Treviño; Alfonso Díaz
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 2.  Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.

Authors:  Manali Tilak; Jennifer Holborn; Laura A New; Jasmin Lalonde; Nina Jones
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

3.  SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma.

Authors:  Xin Zhang; Hongwei Zhang; Jia Yu; Keshuai Dong; Zhibin Liao; Jiacheng Zhang; Huifang Liang; Weixing Wang
Journal:  Cancer Cell Int       Date:  2022-01-15       Impact factor: 5.722

4.  The role of the ShcD and RET interaction in neuroblastoma survival and migration.

Authors:  Zeanap A Mabruk; Samrein B M Ahmed; Asha Caroline Thomas; Sally A Prigent
Journal:  Biochem Biophys Rep       Date:  2018-01-28

5.  Localization of phosphotyrosine adaptor protein ShcD/SHC4 in the adult rat central nervous system.

Authors:  Hannah N Robeson; Hayley R Lau; Laura A New; Jasmin Lalonde; John N Armstrong; Nina Jones
Journal:  BMC Neurosci       Date:  2019-12-10       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.